New User? Sign Up | Sign In

Insider Trading - Akero Therapeutics Inc. (AKRO)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
AKRO Insider Trading Transactions for Akero Therapeutics Inc.
Goto page 0, 1, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2019-12-17
Sale
2019-12-19
9:30 pm
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
10% Owner
9,671 $19.56 $189,197 4,095,187
(Direct)
View
2019-12-20
Sale
2019-12-26
8:59 pm
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
10% Owner
49,220 $21.34 $1,050,416 4,045,967
(Direct)
View
2019-12-27
Sale
2019-12-31
6:05 pm
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
10% Owner
389,382 $24.2 $9,421,175 3,656,585
(Direct)
View
2019-12-27
Sale(A)
2019-12-31
7:11 pm
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
10% Owner
389,382 $24.2 $9,421,175 3,656,585
(Direct)
View
2019-12-31
Sale
2020-01-03
4:13 pm
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
14,324 $23.96 $343,259 3,940,534
(Indirect)
View
2020-01-02
Sale
2020-01-06
4:07 pm
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
35,498 $19.71 $699,721 3,905,036
(Indirect)
View
2020-01-02
Sale
2020-01-06
8:59 pm
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
72,444 $19.7 $1,427,272 3,256,124
(Indirect)
View
2020-01-06
Sale
2020-01-08
4:10 pm
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
73,221 $19.86 $1,454,530 3,831,815
(Indirect)
View
2020-01-07
Sale
2020-01-09
8:11 pm
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
53,057 $19.99 $1,060,845 3,203,067
(Indirect)
View
2020-01-08
Sale
2020-01-10
4:06 pm
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
15,677 $19.86 $311,355 3,816,138
(Indirect)
View
2020-01-13
Sale
2020-01-14
08:58 am
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
494,000 $20.23 $9,993,620 3,322,138
(Indirect)
View
2020-01-10
Sale
2020-01-15
9:53 pm
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
50,837 $20.04 $1,018,571 3,152,230
(Indirect)
View
2020-01-16
Sale
2020-01-21
9:57 pm
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
59,532 $20.87 $1,242,403 3,092,698
(Indirect)
View
2020-02-04
Sale
2020-02-06
4:06 pm
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
82,339 $25.77 $2,121,726 3,239,799
(Indirect)
View
2020-02-06
Sale
2020-02-10
5:47 pm
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
6,102 $27.03 $164,955 3,233,697
(Indirect)
View
2020-02-11
Sale
2020-02-12
5:56 pm
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
10,026 $27.07 $271,399 3,233,671
(Indirect)
View
2020-02-25
Sale
2020-02-27
7:51 pm
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
5,904 $22.8 $134,635 3,227,767
(Indirect)
View
2020-02-28
Sale
2020-03-03
5:52 pm
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
21,798 $22.63 $493,310 3,195,969
(Indirect)
View
2020-03-04
Sale
2020-03-06
5:23 pm
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
45,950 $23.76 $1,091,608 3,150,019
(Indirect)
View
2020-07-01
Sale
2020-07-06
7:00 pm
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
116,467 $34.4 $4,006,537 3,033,552
(Indirect)
View
2020-01-02
Sale(A)
2020-07-10
8:28 pm
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
72,444 $19.7 $1,427,272 2,899,998
(Indirect)
View
2020-01-07
Sale(A)
2020-07-10
8:28 pm
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
53,057 $19.99 $1,060,845 2,846,941
(Indirect)
View
2020-07-10
Purchase
2020-07-14
4:45 pm
Akero Therapeutics Inc. AKRO Harrison Seth Loring
Director
10% Owner
415,000 $36 $14,940,000 5,830,203
(Indirect)
View
2020-07-10
Purchase
2020-07-14
4:46 pm
Akero Therapeutics Inc. AKRO Apple Tree Partners IV L.P.
ATP III GP Ltd.
10% Owner
415,000 $36 $14,940,000 5,830,203
(Direct)
View
(A) Indicate amendment filing.

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2019-12-30
Acquisition
2019-12-31
4:16 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Young Jonathan
COO
667 $0 193,576
(Direct)
View
2019-12-31
Other
2020-01-02
5:19 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Atlas Venture Fund XI L.P.
10% Owner
242,883 $0 2,706,412
(Indirect)
View
2019-12-31
Option Award
2020-01-03
6:15 pm
N/A
N/A
Akero Therapeutics Inc. AKRO White William Richard
CFO
1,025 $18.87 1,025
(Direct)
View
2019-12-31
Option Award
2020-01-03
6:16 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Yale Catriona
Chief Development Officer
1,025 $18.87 163,669
(Direct)
View
2019-12-31
Option Award
2020-01-03
6:16 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Cheng Andrew
CEO
1,025 $18.87 326,314
(Direct)
View
2020-01-02
Other
2020-01-06
8:59 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
684,143 $0 3,256,124
(Indirect)
View
2020-01-02
Other
2020-01-06
8:59 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
13,683 $0 3,256,124
(Indirect)
View
2020-01-02
Other
2020-01-06
8:59 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
13,683 $0 3,256,124
(Indirect)
View
2020-01-02
Other
2020-01-06
8:59 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
11,803 $0 3,256,124
(Indirect)
View
2020-01-02
Other
2020-01-06
8:59 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
11,803 $0 3,256,124
(Indirect)
View
2020-01-10
Exercise
2020-01-10
7:39 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Young Jonathan
COO
17,621 $0.615 100,350
(Direct)
View
2020-01-10
Exercise
2020-01-10
7:39 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Young Jonathan
COO
21,286 $0.615 100,350
(Direct)
View
2020-01-10
Exercise
2020-01-10
7:39 pm
N/A
2028-07-29
Akero Therapeutics Inc. AKRO Young Jonathan
COO
17,621 $0.615 100,350
(Direct)
View
2020-01-10
Exercise
2020-01-10
7:39 pm
N/A
2028-10-17
Akero Therapeutics Inc. AKRO Young Jonathan
COO
21,286 $0.615 100,350
(Direct)
View
2020-02-07
Other
2020-02-10
7:49 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Atlas Venture Opportunity Fund I L.P.
10% Owner
50,510 $0 404,079
(Indirect)
View
2020-03-12
Exercise
2020-03-13
7:04 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Rolph Timothy
Chief Scientific Officer
27,368 $0.61 42,796
(Direct)
View
2020-03-12
Exercise
2020-03-13
7:04 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Rolph Timothy
Chief Scientific Officer
22,656 $0.61 42,796
(Direct)
View
2020-03-12
Exercise
2020-03-13
7:04 pm
N/A
2028-10-17
Akero Therapeutics Inc. AKRO Rolph Timothy
Chief Scientific Officer
27,368 $0.61 42,796
(Direct)
View
2020-03-12
Exercise
2020-03-13
7:04 pm
N/A
2028-07-29
Akero Therapeutics Inc. AKRO Rolph Timothy
Chief Scientific Officer
22,656 $0.61 42,796
(Direct)
View
2020-03-13
Exercise
2020-03-16
5:51 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Young Jonathan
COO
5,035 $0.615 94,268
(Direct)
View
2020-03-13
Exercise
2020-03-16
5:51 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Young Jonathan
COO
6,082 $0.615 94,268
(Direct)
View
2020-03-13
Exercise
2020-03-16
5:51 pm
N/A
2028-07-29
Akero Therapeutics Inc. AKRO Young Jonathan
COO
5,035 $0.615 94,268
(Direct)
View
2020-03-13
Exercise
2020-03-16
5:51 pm
N/A
2028-10-17
Akero Therapeutics Inc. AKRO Young Jonathan
COO
6,082 $0.615 94,268
(Direct)
View
2020-03-30
Exercise
2020-04-01
6:52 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Graham G. Walmsley
Director
2,168 $19.97 23,832
(Direct)
View
2020-03-30
Exercise
2020-04-01
6:52 pm
N/A
2029-11-07
Akero Therapeutics Inc. AKRO Graham G. Walmsley
Director
2,168 $19.97 23,832
(Direct)
View
2020-06-01
Option Award
2020-06-02
6:52 pm
N/A
2030-05-31
Akero Therapeutics Inc. AKRO Harrison Seth Loring
Director
10% Owner
13,000 $25.2 13,000
(Direct)
View
2020-06-01
Option Award
2020-06-02
6:53 pm
N/A
2030-05-31
Akero Therapeutics Inc. AKRO Graham G. Walmsley
Director
13,000 $25.2 13,000
(Direct)
View
2020-06-01
Option Award
2020-06-02
6:54 pm
N/A
2030-05-31
Akero Therapeutics Inc. AKRO Bitterman Kevin
Director
13,000 $25.2 13,000
(Direct)
View
2020-06-01
Option Award
2020-06-02
6:54 pm
N/A
2030-05-31
Akero Therapeutics Inc. AKRO Iwicki Mark T
Director
13,000 $25.2 13,000
(Direct)
View
2020-06-01
Option Award
2020-06-02
6:54 pm
N/A
2030-05-31
Akero Therapeutics Inc. AKRO Henderson Jane
Director
13,000 $25.2 13,000
(Direct)
View
2020-06-09
Option Award
2020-06-11
7:01 pm
N/A
2030-06-09
Akero Therapeutics Inc. AKRO Heyman Tomas J.
Director
26,000 $25.04 26,000
(Direct)
View
2020-01-02
Other
2020-07-10
8:28 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
684,143 $0 2,899,998
(Indirect)
View
2020-01-02
Other
2020-07-10
8:28 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
13,683 $0 2,899,998
(Indirect)
View
2020-01-02
Other
2020-07-10
8:28 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
13,683 $0 2,899,998
(Indirect)
View
2020-01-02
Other
2020-07-10
8:28 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
11,803 $0 2,899,998
(Indirect)
View
2020-01-02
Other
2020-07-10
8:28 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
10% Owner
11,803 $0 2,899,998
(Indirect)
View
Goto page 0, 1, Next